Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who are receiving palliative or curative treatment for cancer of the mouth, nose, or throat area
- People whose treatment plan includes radiotherapy, with or without additional treatments such as chemotherapy or immunotherapy, for a course of between 10 and 35 radiotherapy sessions
- People who have read, dated, and signed a consent form agreeing to take part in the trial
Who may not be able to join:
- People who have uncontrollable body movements
- People who are currently under psychiatric care
- People who do not understand or read French
- People who are already participating in another clinical trial that is testing a different medical intervention
- People who are under guardianship, legal protection, or curatorship, or who are currently deprived of their liberty
- Women who are pregnant or breastfeeding
- People who do not have social security coverage
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Coralie Geffroy, Centre de Lutte contre le Cancer Eugène Marquis
Phone: 02 99 25 31 65
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurement patient displacement during surface-guided radiotherapy sessions
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.